IL22 and graft versus host disease: MSCs can promote the proliferation and IL-22 production of ILC3s, potentially involved in the protection against tissue damage induced by GVHD and other inflammatory diseases, and reciprocally ILC3s increase ICAM-1 and VCAM-1 expression on MSCs [113].